Meeting
2017 ASCO Annual Meeting
Investigation of the immune infiltrate of melanoma metastases under immune checkpoint inhibition.
Authors
Jessica Cecile Hassel
University Hospital Heidelberg, Heidelberg, Germany
Jessica Cecile Hassel , Michael Flossdorf , Sonja Hänzelmann , Julia Winkler , Jasmin Roth , Claudia Lauenstein , Lena Appel , Enrico Streit , Niels Halama , Marta Faryna , Alexander Enk , Rienk Offringa , Ugur Sahin , Isabel Poschke
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Biologic Correlates
Citation
J Clin Oncol 35, 2017 (suppl; abstr 9570)
DOI
10.1200/JCO.2017.35.15_suppl.9570
Abstract #
9570
Poster Bd #
178
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Investigation of intrapatient heterogeneity in the tumor infiltrating T cell repertoire in patients with metastatic melanoma treated with pembrolizumab.
First Author: Rodrigo Ramella Munhoz
Poster
2023 ASCO Annual Meeting
Immune infiltrates in metastatic uveal melanoma liver metastases and associations with clinical outcomes.
First Author: Katherine Emilie Rhoades Smith
Poster
2023 ASCO Genitourinary Cancers Symposium
Digital evaluation of tumor microenvironment immune markers pre- and post-neoadjuvant pembrolizumab in muscle-invasive bladder cancer (Pure-01 trial: An open label, single arm, phase II study).
First Author: Laura Cattaneo
Poster
2020 ASCO Virtual Scientific Program
The impact of BRAF mutation status on clinical outcomes with single-agent PD-1 inhibitor versus combination ipilimumab/nivolumab.
First Author: Vincent The-Luc Ma